See more : BRP Inc. (DOOO) Income Statement Analysis – Financial Results
Complete financial analysis of Retractable Technologies, Inc. (RVP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Retractable Technologies, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Shanghai Maling Aquarius Co.,Ltd (600073.SS) Income Statement Analysis – Financial Results
- Barloworld Limited (BRRAF) Income Statement Analysis – Financial Results
- Grupo Catalana Occidente, S.A. (GCNJF) Income Statement Analysis – Financial Results
- Jiangsu Kuangshun Photosensitivity New-Material Stock Co., Ltd. (300537.SZ) Income Statement Analysis – Financial Results
- Sprott Physical Platinum and Palladium Trust (SPPP.TO) Income Statement Analysis – Financial Results
Retractable Technologies, Inc. (RVP)
About Retractable Technologies, Inc.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.60M | 94.82M | 188.38M | 81.86M | 41.80M | 33.27M | 34.49M | 29.83M | 29.55M | 34.52M | 30.79M | 33.64M | 32.10M | 36.22M | 38.98M | 27.90M | 26.29M | 25.32M | 24.24M | 21.52M | 19.08M | 20.32M | 16.15M | 9.64M |
| Cost of Revenue | 34.49M | 66.57M | 93.03M | 44.85M | 27.66M | 23.05M | 24.52M | 19.48M | 18.99M | 22.50M | 20.48M | 22.47M | 21.20M | 23.82M | 25.47M | 19.67M | 18.30M | 17.78M | 15.43M | 16.41M | 14.65M | 14.99M | 13.32M | 7.88M |
| Gross Profit | 9.11M | 28.25M | 95.35M | 37.01M | 14.14M | 10.22M | 9.97M | 10.34M | 10.57M | 12.02M | 10.31M | 11.18M | 10.90M | 12.40M | 13.52M | 8.23M | 7.99M | 7.55M | 8.81M | 5.11M | 4.42M | 5.33M | 2.82M | 1.76M |
| Gross Profit Ratio | 20.89% | 29.80% | 50.62% | 45.21% | 33.83% | 30.72% | 28.91% | 34.67% | 35.75% | 34.82% | 33.49% | 33.22% | 33.96% | 34.25% | 34.67% | 29.49% | 30.39% | 29.80% | 36.34% | 23.75% | 23.19% | 26.21% | 17.48% | 18.30% |
| Research & Development | 581.17K | 525.73K | 901.38K | 574.53K | 516.10K | 621.37K | 740.57K | 571.84K | 607.53K | 616.78K | 837.07K | 871.85K | 815.02K | 885.45K | 1.03M | 1.07M | 1.07M | 958.80K | 934.21K | 626.94K | 561.14K | 337.93K | 756.54K | 899.15K |
| General & Administrative | 14.31M | 24.04M | 17.38M | 8.30M | 6.43M | 6.78M | 8.35M | 8.80M | 9.33M | 9.60M | 10.99M | 10.02M | 10.74M | 14.26M | 18.81M | 12.77M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 0.00 | 0.00 |
| Selling & Marketing | 5.71M | 4.54M | 4.48M | 4.06M | 4.22M | 4.40M | 4.66M | 4.03M | 3.84M | 3.97M | 4.41M | 4.22M | 3.44M | 3.67M | 4.37M | 4.84M | 5,299.16B | 5.55B | 4.15B | 3.65M | 3.37M | 4.04M | 0.00 | 0.00 |
| SG&A | 20.01M | 28.58M | 21.86M | 12.36M | 10.65M | 11.18M | 13.01M | 12.82M | 13.17M | 13.56M | 15.40M | 14.24M | 14.18M | 17.93M | 23.19M | 17.61M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 8.78M | 10.37M |
| Other Expenses | 0.00 | -3.83M | -425.16K | 0.00 | 0.00 | 0.00 | 0.00 | 456.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 365.30M | 2,594.60B | 18.67B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.32M | 8.78M | 10.37M |
| Operating Expenses | 20.60M | 25.27M | 22.33M | 12.94M | 11.17M | 11.80M | 13.75M | 13.39M | 13.77M | 14.18M | 16.24M | 15.12M | 14.99M | 18.82M | 24.22M | 18.67M | 17.94M | 14.26M | 11.68M | 13.11M | 10.33M | 11.23M | 9.54M | 11.27M |
| Cost & Expenses | 55.09M | 91.84M | 115.36M | 57.79M | 38.83M | 34.86M | 38.27M | 32.88M | 32.76M | 36.68M | 36.72M | 37.58M | 36.19M | 42.63M | 49.68M | 38.34M | 36.24M | 32.04M | 27.11M | 29.52M | 24.98M | 26.22M | 22.86M | 19.15M |
| Interest Income | 1.45M | 9.95K | 780.00K | 2.26M | 351.17K | 144.12K | 65.70K | 26.52K | 24.92K | 33.94K | 38.94K | 47.00K | 62.60K | 32.32K | 57.60K | 855.69K | 1.87M | 1.98M | 1.37M | 475.12K | 44.55K | 10.04K | 51.94K | 204.20K |
| Interest Expense | 152.17K | 170.65K | 227.18K | 260.26K | 166.90K | 177.19K | 210.76K | 213.30K | 219.67K | 222.81K | 230.58K | 231.21K | 240.48K | 302.84K | 21.89K | 54.36K | 326.30K | 411.15K | 339.69K | 243.92K | 307.14K | 446.39K | 553.62K | 203.78K |
| Depreciation & Amortization | 7.53M | 4.60M | 1.26M | 832.07K | 852.08K | 886.81K | 834.95K | 872.87K | 858.39K | 1.07M | 1.28M | 1.34M | 1.31M | 1.52M | 1.40M | 1.40M | 1.43M | 1.43M | 1.37M | 1.29M | 1.31M | 1.33M | 1.20M | 938.57K |
| EBITDA | -1.24M | 9.94M | 76.44M | 27.17M | 4.18M | -289.26K | -2.88M | -2.61M | 5.40M | -1.05M | -4.61M | -2.56M | 2.98M | 4.04M | -11.84M | -8.19M | -6.66M | -3.31M | -137.09K | -8.00M | -4.59M | -4.58M | -5.52M | -8.57M |
| EBITDA Ratio | -2.84% | 8.01% | 39.84% | 33.18% | 9.99% | -1.65% | -8.34% | -7.21% | -7.87% | -3.04% | -14.97% | -7.60% | -8.46% | -13.44% | -23.72% | -29.36% | -32.39% | -20.88% | -6.23% | -377.94% | -96.83% | -8.75% | -34.17% | -88.87% |
| Operating Income | -11.49M | 2.99M | 72.60M | 24.07M | 2.97M | -1.32M | -3.78M | -3.51M | -3.21M | -2.16M | -5.93M | -3.94M | -4.09M | -6.78M | -13.30M | -10.44M | -9.95M | -6.71M | -2.88M | -8.00M | -5.90M | -6.39M | -6.71M | -10.45M |
| Operating Income Ratio | -26.35% | 3.15% | 38.54% | 29.40% | 7.11% | -3.97% | -10.95% | -11.76% | -10.85% | -6.25% | -19.27% | -11.71% | -12.74% | -18.72% | -34.11% | -37.44% | -37.83% | -26.51% | -11.87% | -37.17% | -30.94% | -31.45% | -41.58% | -108.33% |
| Total Other Income/Expenses | 2.57M | 6.02M | 2.36M | 2.00M | 184.27K | 236.78K | -145.07K | -642.89K | 7.53M | -188.87K | -191.64K | -184.21K | 5.52M | 8.64M | -2.56M | 801.33K | 1.54M | 1.57M | 1.03M | 74.87M | 13.62M | -436.36K | 0.00 | 734.79K |
| Income Before Tax | -8.92M | 5.16M | 74.95M | 26.07M | 3.16M | -1.35M | -3.92M | -3.69M | 4.32M | -2.35M | -6.12M | -4.12M | 1.43M | 2.22M | -13.26M | -9.64M | -8.40M | -5.15M | -1.84M | 66.87M | 7.71M | -6.83M | 0.00 | 0.00 |
| Income Before Tax Ratio | -20.45% | 5.44% | 39.79% | 31.85% | 7.55% | -4.07% | -11.37% | -12.38% | 14.63% | -6.80% | -19.89% | -12.25% | 4.46% | 6.14% | -34.02% | -34.57% | -31.96% | -20.33% | -7.61% | 310.70% | 40.43% | -33.60% | 0.00% | 0.00% |
| Income Tax Expense | -1.91M | 83.87K | 18.89M | 1.85M | 7.88K | -13.32K | -187.61K | 1.13K | 7.88K | 8.18K | 90.97K | 9.82K | 13.80K | -176.06K | -3.84M | 855.69K | -1.45M | -1.28M | -605.36K | 12.18M | 265.47K | 917.99K | 501.67K | 938.15K |
| Net Income | -7.01M | 5.08M | 56.06M | 24.22M | 3.15M | -1.34M | -3.74M | -3.69M | 4.31M | -2.35M | -6.21M | -4.13M | 1.42M | 2.40M | -9.42M | -9.64M | -6.95M | -3.87M | -1.24M | 54.69M | 7.45M | -6.83M | -7.22M | -10.44M |
| Net Income Ratio | -16.08% | 5.36% | 29.76% | 29.59% | 7.53% | -4.03% | -10.83% | -12.39% | 14.60% | -6.82% | -20.18% | -12.28% | 4.42% | 6.63% | -24.17% | -34.57% | -26.43% | -15.28% | -5.11% | 254.12% | 39.04% | -33.60% | -44.69% | -108.33% |
| EPS | -0.24 | 0.15 | 1.65 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.21 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.23 | -0.34 | -0.36 | -0.71 |
| EPS Diluted | -0.24 | 0.15 | 1.63 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.20 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.20 | -0.34 | -0.36 | -0.54 |
| Weighted Avg Shares Out | 29.94M | 32.90M | 33.87M | 33.17M | 32.67M | 32.67M | 31.72M | 29.33M | 27.82M | 27.25M | 27.00M | 26.22M | 24.17M | 23.87M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 22.60M | 21.00M | 20.30M | 19.77M | 14.72M |
| Weighted Avg Shares Out (Dil) | 29.94M | 32.96M | 34.24M | 33.30M | 32.67M | 32.67M | 31.96M | 29.35M | 29.48M | 27.38M | 27.00M | 26.22M | 26.35M | 26.25M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 25.48M | 24.44M | 20.30M | 19.77M | 19.37M |
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2023
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its loss from operations was $8.7 million for the first nine months of 2023 and that it had an operating loss of $936 thousand for the third quarter of...
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of...
Retractable Technologies, Inc. Results for the Period Ended June 30, 2023
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $8.0 million for the second quarter of 2023 and an operating loss of $5.0 million for the second quarter, as compared to total net sales for...
Retractable Technologies Offers At Least 100% Potential Upside
Retractable Technologies (NYSE:RVP) is a hidden gem trading below our assessed liquidation value of $2.25 per share. The company is well-positioned to get back into profitable territory soon.
Top 10 Quality, Value & Momentum Quant Stocks for December Revealed Here
The 10 stocks featured in this article are featured from Fintel's QVM (Quality, Value & Momentum) stock screen this week.
7 Penny Stocks Primed for Huge Moves in December
Although respected financial analysts consistently steer their clients away from penny stocks, they still attract new recruits. Obviously, the allure of quick riches represents a universal temptation.
Retractable Technologies: A Very Promising Small-Cap Healthcare Stock
Retractable Technologies has developed a unique product different from its competition. The medical supply industry is a huge growing industry with constant demand to meet healthcare needs.
Safety Medical Devices-Focused Retractable Tech Cuts Its Workforce
Retractable Technologies Inc (NYSE: RVP) has reduced its workforce by approximately 16% due to the substantial completion of its facility expansion efforts and the completion of U.S. government orders to provide its products for COVID-19 vaccination efforts. The staff.
Penny Stocks To Buy Now? Insiders Threw Big Money At These 4 Stocks
Penny stocks to buy according to these insiders. The post Penny Stocks To Buy Now?
Here's What Warren Buffett Looks For With Healthcare Stocks
There's a reason why there are so few of them in his portfolio.
Source: https://incomestatements.info
Category: Stock Reports